Showing results (161-170 of 250) with videos related to

Sort By:
Pageof 25
The American Journal on Addictions|August 16, 2011
A comparison of independent depression and substance-induced depression in cannabis-, cocaine-, and opioid-dependent treatment seekersElias Dakwar, Edward V Nunes, Adam Bisaga, et al.
The American Journal of Drug and Alcohol Abuse|February 9, 2018
Open-label pilot study of injectable naltrexone for cannabis dependenceDaniel P Notzon, Meredith A Kelly, C Jean Choi, et al.
Pediatrics|December 22, 2025
Cannabis Use Among US AdolescentsRyan S Sultan, Alexander W Zhang, Timothy D Becker, et al.
Drug and Alcohol Dependence|January 4, 2015
Opioid use and dropout in patients receiving oral naltrexone with or without single administration of injection naltrexoneMaria A Sullivan, Adam Bisaga, Andrew Glass, et al.
The American Journal on Addictions|July 5, 2021
Open-label trial of a single-day induction onto buprenorphine extended-release injection for users of heroin and fentanylJohn J Mariani, Amy L Mahony, Samuel C Podell, et al.
Drug and Alcohol Dependence|July 1, 2011
A placebo controlled trial of memantine as an adjunct to oral naltrexone for opioid dependenceAdam Bisaga, Maria A Sullivan, Wendy Y Cheng, et al.
Addiction (Abingdon, England)|January 10, 2013
A randomized double-blind, placebo-controlled trial of venlafaxine-extended release for co-occurring cannabis dependence and depressive disordersFrances R Levin, John Mariani, Daniel J Brooks, et al.
BMC Cancer|December 20, 2017
Process evaluation of health fairs promoting cancer screeningsCam Escoffery, Shuting Liang, Kirsten Rodgers, et al.
Pain Medicine (Malden, Mass.)|August 19, 2021
First-Year Trajectories of Medical Cannabis Use Among Adults Taking Opioids for Chronic Pain: An Observational Cohort StudyJonathan Ross, Deepika E Slawek, Chenshu Zhang, et al.
Pageof 25